ProPharma

ProPharma is a global consulting firm specializing in regulatory sciences, clinical research, and compliance services for pharmaceutical, biotechnology, and medical device companies. Operating for over 25 years, the company provides end-to-end support throughout the product development lifecycle, from early-stage development through post-market commercialization.

The firm's service portfolio spans seven core areas: regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, functional service provider (FSP) solutions, and digital transformation. ProPharma maintains global operations with offices across multiple regions, including a recent expansion to Hyderabad, India, and offers 24/7/365 medical information contact center capabilities.

Recent recognition includes awards from ECCCSA for AI innovation in medical information, the 2024 CPHI Regulatory and Compliance Award, and Clinical Trials Excellence Awards. The company has committed to net-zero emissions by 2050 with Science Based Targets initiative (SBTi) validation.

Organizations should consider ProPharma when they need proven regulatory and clinical expertise to navigate complex approval processes or manage post-market compliance obligations. The firm's integrated service model allows clients to access multiple specialized functions through a single partner, reducing coordination overhead across regulatory, clinical, and safety operations.

Expect a partnership-driven approach with dedicated program managers and asset strategists who assemble specialized teams based on specific development stage needs. The company's global footprint and 24/7 operations capability make it suitable for multinational programs requiring consistent quality across regions.

ProPharma operates exclusively within the life sciences healthcare sector, serving pharmaceutical, biotechnology, and medical device manufacturers. The firm's healthcare specialization encompasses regulatory compliance for FDA and EMA submissions, Good Laboratory Practice (GLP) compliance, clinical trial management across multiple therapeutic areas, and pharmacovigilance for drug safety monitoring.

Their healthcare expertise extends to supporting therapies across diverse therapeutic areas, with documented experience in complex conditions like acute ischemic stroke, oncology, and other specialized treatment domains requiring stringent regulatory oversight and patient safety protocols.

Mid-sized to large pharmaceutical and biotechnology companies with complex regulatory requirements across multiple markets, particularly those managing global clinical programs, high-volume pharmacovigilance operations, or products requiring specialized regulatory strategies. Also well-suited for medical device manufacturers navigating FDA and international regulatory pathways, and organizations needing to scale compliance and safety operations rapidly without building internal infrastructure.